Cytotoxic activity of the novel Akt inhibitor, MK-2206, in T-cell acute lymphoblastic leukemia
Carolina Simioni(University of Ferrara), Alberto M. Martelli(University of Bologna)
Cited by 87
Related Papers
Oxidative stress: role of physical exercise and antioxidant nutraceuticals in adulthood and aging
|Oncotarget|2018|510
Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR Cascade Inhibitors: How Mutations Can Result in Therapy Resistance and How to Overcome Resistance
|Oncotarget|2012|315
Mutations and Deregulation of Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR Cascades Which Alter Therapy Response.
|Oncotarget|2012|303